When a clinical trial has no drug to ship, what becomes supply? Non-pharmacological trials still require sourcing, tracking, qualification, and control.
- AI In Clinical Supply: From Forecasting To Execution Decisions
- Accountability Gaps Can Break Clinical Supply Contracts
- When Clinical Supply Becomes A Clinical Decision
- How To Build Clinical Supply Into Drug Development From The Start
- When Communication Fails, Clinical Supply Risk Grows
- When IRT Configuration Decisions Disrupt Clinical Supply
- Fixing The Data Problem Before AI Can Help Clinical Trial Supply
- The Shipment Arrived. The Inventory Didn't: Understanding The Hidden Data Dependencies Behind Depot-To-Site Deliveries
ON-DEMAND WEBINARS
Achieving supply chain resilience is crucial, and flexible distribution strategies and ready-to-use depot and logistics networks are instrumental in establishing limitless flexibility and expertise capable of identifying possible risks.
The complexities of sample collection and logistics in advanced therapy studies naturally brings chain of custody challenges in protecting the integrity of a trials’ high value samples. Learn about end to end sample management strategies, logistical integration planning, real-time tracking and LIVE monitoring technologies.
Understand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.
Consider these strategies when anticipating and mitigating disruptions, and how future innovations and trends will continue to shape the logistics industry.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![West]( "Vial Containment Systems For Gene And Cell Therapies")
Vial Containment Systems For Gene And Cell TherapiesCZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.
-
![iStock-649856194-doctor-packaging-trial]( "Logistics, Transport Challenges Require Complex Solutions")
Logistics, Transport Challenges Require Complex SolutionsThe pandemic created additional obstacles for the clinical supply chain. Ensuring continued clinical trial operation requires an optimal management solution for clinical material supply.
-
![GettyImages-1334686671-cold-chain-cryopreservation-logistics]( "Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage")
Overcoming The Challenge Of Maintaining Sterility At Low Temperature StorageLearn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.
-
![Pharmaceutical-Drug-Manufacturing-GettyImages-1405788565]( "Specializing In Small And Early-Stage Partners, Not Just Small Batches")
Specializing In Small And Early-Stage Partners, Not Just Small BatchesMany small and/or early-stage companies are not aware of the need, or the possibility, of finding a CDMO that specializes in meeting their specific requirements.
-
![GettyImages-871431000 doctor partner]( "3 Reasons Sponsors Should Own The RTSM Vendor Relationship")
3 Reasons Sponsors Should Own The RTSM Vendor RelationshipExplore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.
-
![supply chain checklist pharmaceuticals-GettyImages-1616023386]( "Revolutionizing Trial Supply Management With The Power Of Free Picking")
Revolutionizing Trial Supply Management With The Power Of Free PickingDiscover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
-
![GettyImages-1201133478 biosample]( "Biosample Tracking: A Consenting Dilemma")
Biosample Tracking: A Consenting DilemmaBiosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.
-
![Scientist research laboratory pipette GettyImages-487041629]( "Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions")
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And SolutionsExplore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.
-
![electronic-medical-technology-GettyImages-1204743045]( "Benefits Of Electronic Labels: Investigational Medicinal Products")
Benefits Of Electronic Labels: Investigational Medicinal ProductsWhen a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
-
![Internet-Medical-Things-iStock-914789708]( "How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers")
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment NumbersExplore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
